The Association Between Body Mass Index and Remission Rates in Patients With Treatment-Resistant Depression Who Received Intravenous Ketamine

被引：9
|
作者：
Singh, Balwinder [1 ]
Bobo, William V. [2 ]
Rasmussen, Keith G. [1 ]
Stoppel, Cynthia J. [1 ]
Rico, Jose A., Jr. [1 ]
Schak, Kathryn M. [1 ]
Biernacka, Joanna M. [1 ,3 ]
Frye, Mark A. [1 ]
Vande Voort, Jennifer L. [1 ]
机构：
[1] Mayo Clin, Coll Med, Dept Psychiat & Psychol, Depress Ctr, Rochester, MN 55905 USA
[2] Mayo Clin, Coll Med, Dept Psychiat & Psychol, Jacksonville, FL 32224 USA
[3] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA
来源：
JOURNAL OF CLINICAL PSYCHIATRY | 2019年 / 80卷 / 06期
关键词：
D-ASPARTATE ANTAGONIST; TRIAL;
D O I：
10.4088/JCP.19l12852
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页数：6
相关论文
共 50 条
  • [21] Repeated intravenous ketamine therapy in a patient with treatment-resistant major depression
    Liebrenz, Michael
    Stohler, Rudolf
    Borgeat, Alain
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2009, 10 (04): : 640 - 643
  • [22] Metabolomic signatures of intravenous racemic ketamine associated remission in treatment-resistant depression: A pilot hypothesis generating study
    Singh, Balwinder
    MahmoudianDehkordi, Siamak
    Vande Voort, Jennifer L.
    Han, Xianlin
    Port, John D.
    Frye, Mark A.
    Kaddurah-Daouk, Rima
    PSYCHIATRY RESEARCH, 2022, 314
  • [23] A Case of Sustained Remission Following an Acute Course of Ketamine in Treatment-Resistant Depression
    Murrough, James W.
    Perez, Andrew M.
    Mathew, Sanjay J.
    Charney, Dennis S.
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (03) : 414 - 415
  • [24] Patients? recovery and non-recovery narratives after intravenous ketamine for treatment-resistant depression
    Lapidos, Adrienne
    Lopez-Vives, Daniela
    Sera, Cortney E.
    Ahearn, Elizabeth
    Vest, Erica
    Senic, Ivana
    Voort, Jennifer L. Vande
    Frye, Mark
    Goes, Fernando S.
    Achtyes, Eric
    Greden, John
    V. Parikh, Sagar
    JOURNAL OF AFFECTIVE DISORDERS, 2023, 323 : 534 - 539
  • [25] Intravenous subanesthetic ketamine: an innovative treatment option for rapid response in treatment-resistant depression
    Kang, M.
    Hawken, E.
    Bahji, A.
    Brietzke, E.
    Vazquez, G.
    EUROPEAN PSYCHIATRY, 2020, 63 : S113 - S113
  • [26] Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression
    Salloum, Naji C.
    Fava, Maurizio
    Freeman, Marlene P.
    Flynn, Martina
    Hoeppner, Bettina
    Hock, Rebecca S.
    Cusin, Cristina
    Iosifescu, Dan V.
    Trivedi, Madhukar H.
    Sanacora, Gerard
    Mathew, Sanjay J.
    Debattista, Charles
    Ionescu, Dawn F.
    Papakostas, George I.
    DEPRESSION AND ANXIETY, 2019, 36 (03) : 235 - 243
  • [27] Effects of Repeated Intravenous Ketamine in Treatment-Resistant Geriatric Depression A Case Series
    Bryant, Kelly A.
    Altinay, Murat
    Finnegan, Nora
    Cromer, Kim
    Dale, Roman M.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2019, 39 (02) : 158 - 161
  • [28] Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant Depression
    Price, Rebecca B.
    Nock, Matthew K.
    Charney, Dennis S.
    Mathew, Sanjay J.
    BIOLOGICAL PSYCHIATRY, 2009, 66 (05) : 522 - 526
  • [29] Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
    aan het Rot, Marije
    Collins, Katherine A.
    Murrough, James W.
    Perez, Andrew M.
    Reich, David L.
    Charney, Dennis S.
    Mathew, Sanjay J.
    BIOLOGICAL PSYCHIATRY, 2010, 67 (02) : 139 - 145
  • [30] Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression
    Shiroma, Paulo R.
    Johns, Brian
    Kuskowski, Michael
    Wels, Joseph
    Thuras, Paul
    Albott, C. Sophia
    Lim, Kelvin O.
    JOURNAL OF AFFECTIVE DISORDERS, 2014, 155 : 123 - 129
12345